19-2210825-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032482.3(DOT1L):c.1321G>A(p.Val441Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,612,594 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032482.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOT1L | NM_032482.3 | c.1321G>A | p.Val441Met | missense_variant | 14/28 | ENST00000398665.8 | NP_115871.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DOT1L | ENST00000398665.8 | c.1321G>A | p.Val441Met | missense_variant | 14/28 | 1 | NM_032482.3 | ENSP00000381657 | P2 | |
DOT1L | ENST00000686010.1 | c.1321G>A | p.Val441Met | missense_variant | 14/28 | ENSP00000510335 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152102Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 247290Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134874
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460492Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726538
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152102Hom.: 0 Cov.: 33 AF XY: 0.0000808 AC XY: 6AN XY: 74268
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 07, 2024 | The c.1321G>A (p.V441M) alteration is located in exon 14 (coding exon 14) of the DOT1L gene. This alteration results from a G to A substitution at nucleotide position 1321, causing the valine (V) at amino acid position 441 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at